Profile data is unavailable for this security.
About the company
Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
- Revenue in USD (TTM)1.48bn
- Net income in USD126.04m
- Incorporated2021
- Employees1.64k
- LocationHims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
- Phone+1 (415) 851-0195
- Fax+1 (302) 655-5049
- Websitehttps://www.forhims.com/
Mergers & acquisitions
| Acquired company | HIMS:NYQ since announced | Transaction value |
|---|---|---|
| C S Bio Co-Peptide Facility | -15.40% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CorVel Corp | 871.31m | 88.20m | 5.34bn | 4.87k | 61.25 | 17.74 | 45.68 | 6.12 | 1.70 | 1.70 | 16.76 | 5.86 | 1.77 | -- | 8.76 | 178,913.30 | 17.93 | 14.87 | 30.48 | 24.21 | 22.40 | 22.14 | 10.12 | 9.16 | -- | -- | 0.00 | 0.00 | 10.68 | 5.95 | 14.90 | 10.57 | 13.87 | -- |
| Option Care Health Inc | 5.00bn | 211.82m | 5.44bn | 6.02k | 26.80 | 3.89 | 19.75 | 1.09 | 1.23 | 1.23 | 28.91 | 8.45 | 1.51 | 12.04 | 12.70 | 830,956.30 | 6.38 | 5.15 | 8.08 | 6.27 | 20.27 | 21.93 | 4.24 | 3.86 | 1.20 | 7.47 | 0.4417 | 0.00 | 16.17 | 16.69 | -20.69 | -- | 4.71 | -- |
| Ensign Group Inc | 4.26bn | 297.97m | 7.22bn | 39.30k | 24.57 | 3.93 | 18.87 | 1.69 | 5.11 | 5.11 | 73.15 | 31.98 | 0.9632 | -- | 8.08 | 108,409.30 | 6.75 | 6.66 | 8.11 | 8.11 | 21.31 | 22.30 | 7.01 | 6.87 | -- | -- | 0.0734 | 5.65 | 14.24 | 15.91 | 42.30 | 26.58 | -5.78 | 4.78 |
| Hims & Hers Health Inc | 1.48bn | 126.04m | 7.54bn | 1.64k | 63.81 | 15.72 | 52.65 | 5.11 | 0.5317 | 0.5317 | 6.24 | 2.16 | 2.57 | 6.98 | 250.58 | 901,963.40 | 21.94 | -3.91 | 30.05 | -4.74 | 79.45 | -- | 8.54 | -2.35 | 1.50 | -- | 0.00 | -- | 69.33 | -- | 635.28 | 155.96 | -- | -- |
| Chemed Corp | 2.43bn | 302.00m | 8.62bn | 15.70k | 29.60 | 7.67 | 23.63 | 3.55 | 19.91 | 19.91 | 160.10 | 76.87 | 1.46 | 156.16 | 13.79 | 154,908.40 | 18.10 | 19.20 | 22.05 | 24.05 | 35.14 | 35.20 | 12.42 | 12.78 | 1.35 | -- | 0.00 | 8.19 | 7.37 | 4.63 | 10.82 | 6.55 | -1.35 | 7.74 |
| Encompass Health Corp | 5.37bn | 455.40m | 9.49bn | 23.56k | 21.14 | 4.60 | 10.56 | 1.77 | 4.46 | 4.43 | 52.61 | 20.51 | 0.8504 | -- | 8.88 | 228,025.80 | 9.49 | 6.72 | 12.35 | 8.39 | 95.55 | 95.41 | 11.16 | 9.53 | -- | 6.51 | 0.4671 | 26.04 | 11.91 | 3.13 | 26.02 | 4.94 | 9.72 | -10.27 |
| Universal Health Services Inc | 15.83bn | 1.14bn | 10.83bn | 86.00k | 9.90 | 1.62 | 6.20 | 0.6842 | 16.83 | 16.83 | 233.12 | 102.59 | 1.11 | -- | 7.17 | 184,045.80 | 8.18 | 6.68 | 9.67 | 7.94 | -- | -- | 7.35 | 6.62 | 1.17 | 9.04 | 0.3998 | 5.63 | 10.82 | 6.82 | 59.17 | 7.04 | 7.56 | 5.92 |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2024 | 27.63m | 13.15% |
| The Vanguard Group, Inc.as of 31 Dec 2024 | 19.68m | 9.37% |
| Farallon Capital Management LLCas of 31 Dec 2024 | 8.38m | 3.99% |
| SSgA Funds Management, Inc.as of 31 Dec 2024 | 7.77m | 3.70% |
| Renaissance Technologies LLCas of 31 Dec 2024 | 6.95m | 3.31% |
| Arrowstreet Capital LPas of 31 Dec 2024 | 6.30m | 3.00% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2024 | 5.19m | 2.47% |
| Geode Capital Management LLCas of 31 Dec 2024 | 4.33m | 2.06% |
| Wellington Management Co. LLPas of 31 Dec 2024 | 3.13m | 1.49% |
| Morgan Stanley & Co. LLCas of 31 Dec 2024 | 2.89m | 1.37% |
